Clinical Trials
14
Active:0
Completed:10
Trial Phases
4 Phases
Phase 2:1
Phase 3:2
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Not Applicable
8 (66.7%)Phase 3
2 (16.7%)Phase 2
1 (8.3%)Phase 4
1 (8.3%)Remote Telemedicine Fetal Monitoring Feasibility Study
Not Applicable
Completed
- Conditions
- UltrasoundCardiotocographyTelemedicinePregnancy, High RiskTelemonitoring
- Interventions
- Device: Pregnabit Pro device and PregnaOne platformDrug: Pulsenmore device
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Birmingham Women's NHS Foundation Trust
- Target Recruit Count
- 15
- Registration Number
- NCT06366711
- Locations
- 🇬🇧
Birmingham Women's Hospital, Birmingham, United Kingdom
Pulsed Electromagnetic Field Treatment for Painful Periods
Not Applicable
- Conditions
- Dysmenorrhea
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2018-06-13
- Lead Sponsor
- Birmingham Women's NHS Foundation Trust
- Target Recruit Count
- 60
- Registration Number
- NCT03394547
- Locations
- 🇬🇧
University of Birmimgham, Birmingham, United Kingdom
An RCT of a Synthetic Osmotic Cervical Dilator for Induction of Labour in Comparison to Dinoprostone Vaginal insErt
Phase 3
Completed
- Conditions
- Induction of Labor Affected Fetus / Newborn
- Interventions
- Device: Dilapan-S
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Birmingham Women's NHS Foundation Trust
- Target Recruit Count
- 674
- Registration Number
- NCT03001661
- Locations
- 🇬🇧
Birmingham Women's and Children's NHS Trust, Birmingham, West Midlands, United Kingdom
Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom
Not Applicable
- Conditions
- Heavy Menstrual Bleeding
- First Posted Date
- 2016-11-22
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Birmingham Women's NHS Foundation Trust
- Target Recruit Count
- 40
- Registration Number
- NCT02971189
Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device
Phase 4
- Conditions
- Heavy Menstrual Bleeding
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2015-05-20
- Lead Sponsor
- Birmingham Women's NHS Foundation Trust
- Target Recruit Count
- 50
- Registration Number
- NCT02449304
- Prev
- 1
- 2
- 3
- Next
News
No news found